Hypertrophic cardiomyopathy: open trials in France

8 open trials have a site in France. Registry data; only the trial team decides who can take part.

NCT07023614
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Trial Treatment · Phase 2 · Imbria Pharmaceuticals, Inc.
Montpellier · Paris · Saint-Herblain
Registry updated 2026-10-26
2024-515125-28-00
A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
Trial Treatment · Phase 2 · Imbria Pharmaceuticals Inc.
Centre Hospitalier Universitaire de Montpellier, Montpellier · Assistance Publique Hopitaux de Paris, Paris · Centre Hospitalier Universitaire de Nantes, Saint-Herblain
Registry updated 2026-10-19
NCT04848506
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
Trial Treatment · Phase 2/3 · Cytokinetics
Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire de Montpellier, Montpellier · Clinique du Millenaire, Montpellier · Assistance Publique Hopitaux de Paris, Paris · Assistance Publique Hopitaux De Paris, Paris Cedex 15 · Centre Hospitalier Universitaire de Bordeaux, Pessac · Centre Hospitalier Universitaire de Rennes, Rennes · Centre Hospitalier Universitaire de Nantes, Saint-Herblain · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9
Registry updated 2026-10-13
NCT05489705
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Research · Bristol-Myers Squibb
Chu Amiens Picardie, Amiens · Centre Hospitalier Haguenau, Haguenau · Hopital Saint Vincent de Paul, Lille · Montpellier · CHU de Poitiers - Hôpital de la Milétrie, Poitiers · CHU Nantes - Hopital Nord Laënnec, Saint-Herblain · Hopital Sainte Musse, Toulon
Registry updated 2026-08-19
NCT07202897
LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
Trial Treatment · Phase 3 · Rennes University Hospital
CHU Angers, Angers · CHU Bordeaux Haut-Levêque, Bordeaux · CHU Brest, Hopital La Cavale Blanche, Brest · CHU Caen, Caen · CHU Dijon Hôpital François Mitterrand, Dijon · CHU Grenoble Alpes, Grenoble · CHU Lille, Lille · Aphm - Hopital La Timone, Marseille · CHU de Nantes - Hopital Nord Laennec, Nantes · Aphp-Hopital Lariboisiere, Paris · AP-HP Höpital la Pitié-Salpétrière, Paris · APHP Hôpital Européen Georges Pompidou, Paris · CHU Rennes - Hopital Pontchaillou, Rennes · CHU de Rouen, Rouen · CHU Rangueil Toulouse, Toulouse · CHU de Tours - Hopital Trousseau, Tours · CHU Nancy, Vandœuvre-lès-Nancy
Registry updated 2026-06-12
NCT07439952
Biological Collection for the Purpose of Exploring Genetic and Clinical-biological Factors Associated With Variability in Response to Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy
Research · Assistance Publique - Hôpitaux de Paris
APHP, Ambroise Paré, Boulogne-Billancourt · APHP, Bicêtre hospital, Le Kremlin-Bicêtre · APHP, La Pitié Salpetriere hospital, Paris
Registry updated 2026-02-27
NCT03846297
Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
Research · Assistance Publique - Hôpitaux de Paris
Centre de référence pour les cardiomyopathies et les troubles du rythme héréditaires ou rares - UF de Génétique, Hôpital Ambroise Paré,, Boulogne-Billancourt
Registry updated 2023-03-16
NCT01091480
French Hypertrophic Cardiomyopathy Observatory
Research · French Cardiology Society
European Georges Pompidou Hospital, Paris
Registry updated 2022-09-21

All Hypertrophic cardiomyopathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error